---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-048877"
form_type: "8-K/A"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2023-09-20T23:59:59+00:00"
generated_at: "2026-06-10T12:42:30.119216+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical amends Investor Day slide: 2026E Adj. EBITDA ex. SBC range raised to $90M-$120M

## Summary
- Adjusted EBITDA ex. SBC for 2026E corrected to $90M-$120M from previously stated $75M-$110M.
- CapEx expected ~$20-$30M annually; 2026E free cash flow estimated at $75-$110M.
- Clarification relates solely to slide 108 of the September 14, 2023 Investor Day presentation.
- No other projections or statements from the original 8-K were amended.

## SEC filing metadata
- accession: 0000950170-23-048877
- form_type: 8-K/A
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2023-09-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000095017023048877/0000950170-23-048877-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000095017023048877/staa-20230914.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-048877
- JSON: https://secwatch.observer/filing/0000950170-23-048877.json
- Plain text: https://secwatch.observer/filing/0000950170-23-048877.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.